Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. 10 all-time greatest Eli Lilly drugs - IndyStar

    www.indystar.com/story/money/2015/12/28/10-all...

    1. Prozac. Famed antidepressant went on sale in 1987. Ushered in a new class of antidepressants and made depression more treatable. Lilly's first multibillion-dollar drug and its best-seller...

  3. Current Medicines | Medicines | Eli Lilly and Company

    www.lilly.com/our-medicines/current-medicines

    Eli Lilly and Company works tirelessly to develop and deliver trusted medicines that meet real needs. These include Trulicity, Humalog, Alimta, Forteo, Taltz, Humulin, Basaglar, Jardiance, Cyramza, REYVOW, Verzenio, Emgality and more.

  4. W eight-loss drugs have made big headlines in health over the past year, and Eli Lillys drug tirzepatide (known as Zepbound for obesity or Mounjaro for diabetes), which received U.S. Food...

  5. Eli Lilly top products by revenue 2022-2023 | Statista

    www.statista.com/statistics/278214/eli-lilly-and...

    In 2023, Trulicity was Eli Lilly's biggest revenue generator with about 7.1 billion U.S. dollars. The next highest revenue generating drug was Mounjaro with about 5.1 billion U.S. dollars.

  6. For more than 90 years, Lilly has been committed to diabetes and meeting the needs of people affected by diabetes with treatment options, support programs and more.

  7. Next-generation drug from Eli Lilly boosts weight loss to 24% ...

    www.cnn.com/2023/06/26/health/weight-loss-next...

    An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...

  8. 3 of Eli Lilly's Top Drugs Grew by Over 40% in Q2. Trulicity ...

    www.fool.com/investing/2023/08/17/3-of-eli-lilly...

    Lilly's top line rose by $1.8 billion this past quarter, and Mounjaro, Verzenio, and Jardiance combined for $1.5 billion of that additional revenue. Those three drugs could be key to the...